Skip to content
10-Q

Quarterly Report

EPIZYME, INC.

0000950170-21-003566

← back to feed
Filed
Nov 9, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2021 · Nov 4, 2021 103.9M sh
Shares Diluted Q3 2021 · Sep 30, 2021 102.51M sh
Shares Diluted Q3 2021 · Sep 30, 2021 102.12M sh
Shares Diluted Q3 2021 · Sep 30, 2020 101.51M sh
Shares Diluted Q3 2021 · Sep 30, 2020 100.75M sh
Capex Q3 2021 · Sep 30, 2021 $387K
Capex Q3 2021 · Sep 30, 2020 $594K
Operating Cash Flow Q3 2021 · Sep 30, 2021 −$174.89M
Operating Cash Flow Q3 2021 · Sep 30, 2020 −$153.22M
Long Term Debt Q3 2021 · Sep 30, 2021 $216.25M
Long Term Debt Q3 2021 · Dec 31, 2020 $215.67M
Cash And Equivalents Q3 2021 · Sep 30, 2021 $124.52M
Cash And Equivalents Q3 2021 · Dec 31, 2020 $168.22M
Cash And Equivalents Q3 2021 · Sep 30, 2020 $93.42M
Stockholders Equity Q3 2021 · Sep 30, 2021 $15.38M
Stockholders Equity Q3 2021 · Jun 30, 2021 $67.63M
Stockholders Equity Q3 2021 · Mar 31, 2021 $123.03M
Stockholders Equity Q3 2021 · Dec 31, 2020 $184.9M
Stockholders Equity Q3 2021 · Sep 30, 2020 $244.41M
Stockholders Equity Q3 2021 · Jun 30, 2020 $293.36M
Stockholders Equity Q3 2021 · Mar 31, 2020 $340.32M
Stockholders Equity Q3 2021 · Dec 31, 2019 $331.14M
Current Liabilities Q3 2021 · Sep 30, 2021 $44.74M
Current Liabilities Q3 2021 · Dec 31, 2020 $43.4M
Current Assets Q3 2021 · Sep 30, 2021 $247.6M
Current Assets Q3 2021 · Dec 31, 2020 $405.09M
Total Assets Q3 2021 · Sep 30, 2021 $332.27M
Total Assets Q3 2021 · Dec 31, 2020 $473.57M
Eps Diluted Q3 2021 · Sep 30, 2021 −$0.64
Eps Diluted Q3 2021 · Sep 30, 2021 −$1.96
Eps Diluted Q3 2021 · Sep 30, 2020 −$0.55
Eps Diluted Q3 2021 · Sep 30, 2020 −$1.64
Eps Basic Q3 2021 · Sep 30, 2021 −$0.64
Eps Basic Q3 2021 · Sep 30, 2021 −$1.96
Eps Basic Q3 2021 · Sep 30, 2020 −$0.55
Eps Basic Q3 2021 · Sep 30, 2020 −$1.64
Sga Expense Q3 2021 · Sep 30, 2021 $32.79M
Sga Expense Q3 2021 · Sep 30, 2021 $103.1M
Sga Expense Q3 2021 · Sep 30, 2020 $30.58M
Sga Expense Q3 2021 · Sep 30, 2020 $90.16M
Rd Expense Q3 2021 · Sep 30, 2021 $34.55M
Rd Expense Q3 2021 · Sep 30, 2021 $102.11M
Rd Expense Q3 2021 · Sep 30, 2020 $25.74M
Rd Expense Q3 2021 · Sep 30, 2020 $77.25M
Net Income Q3 2021 · Sep 30, 2021 −$65.83M
Net Income Q3 2021 · Sep 30, 2021 −$200.47M
Net Income Q3 2021 · Jun 30, 2021 −$64.36M
Net Income Q3 2021 · Mar 31, 2021 −$70.27M
Net Income Q3 2021 · Sep 30, 2020 −$56.07M
Net Income Q3 2021 · Sep 30, 2020 −$165.46M
Net Income Q3 2021 · Jun 30, 2020 −$58.45M
Net Income Q3 2021 · Mar 31, 2020 −$50.94M
Operating Income Q3 2021 · Sep 30, 2021 −$64.14M
Operating Income Q3 2021 · Sep 30, 2021 −$186.71M
Operating Income Q3 2021 · Sep 30, 2020 −$54.36M
Operating Income Q3 2021 · Sep 30, 2020 −$163.27M
Cost Of Revenue Q3 2021 · Sep 30, 2021 $2M
Cost Of Revenue Q3 2021 · Sep 30, 2021 $7.35M
Cost Of Revenue Q3 2021 · Sep 30, 2020 $1.61M
Cost Of Revenue Q3 2021 · Sep 30, 2020 $3.24M